Haduvio (oral nalbuphine ER) is a contrarian opioid. Hold until value is fully realized.
Expected milestones (initiation in 1H 2026)
• Phase3: IPF chronic cough
• Phase2b: RCC
Dilution done / Cash runway into 2028.
cf. Nalbuphine (injectable)
• Approved in 1979
• The only opioid not controlled under the CSA.
投資の参考になりましたか?

